We are live on ! Find out more
CIM

Contravisory Investment Management Portfolio holdings

AUM $566M
1-Year Est. Return 42.93%
This Fund
S&P 500
This Quarter Est. Return
+5.8%
1 Year Est. Return
+42.93%
3 Year Est. Return
+129.34%
5 Year Est. Return
+198.47%
10 Year Est. Return
+603.03%
AUM
$495M
AUM Growth
+$15.3M
Cap. Flow
-$3.32M
Cap. Flow %
-0.67%
Top 10 Hldgs %
32.03%
Holding
182
New
34
Increased
14
Reduced
51
Closed
25

Top Buys

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$11.4M
2
AMAT icon
Applied Materials
AMAT
+$11.3M
3
MCK icon
McKesson
MCK
+$11.2M
4
BUD icon
AB InBev
BUD
+$11.1M
5
KO icon
Coca-Cola
KO
+$9.99M

Top Sells

Rank Stock Value
1
ALV icon
Autoliv
ALV
+$12.5M
2
HAL icon
Halliburton
HAL
+$11.1M
3
BSX icon
Boston Scientific
BSX
+$10.4M
4
BDC icon
Belden
BDC
+$9.87M
5
GG
Goldcorp Inc
GG
+$9.47M

Sector Composition

Rank Sector Weight
1 Healthcare 23.73%
2 Technology 19.2%
3 Industrials 9.85%
4 Materials 9.55%
5 Consumer Staples 9.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GILD icon
1
Gilead Sciences
GILD
$161B
$20.5M 4.14%
217,135
-7,925
-4% -$820K
MCO icon
2
Moody's
MCO
$81.7B
$17.2M 3.48%
179,594
-4,632
-3% -$449K
AMGN icon
3
Amgen
AMGN
$203B
$16.1M 3.25%
101,003
-4,250
-4% -$662K
CTAS icon
4
Cintas
CTAS
$82.4B
$16M 3.23%
814,216
-27,752
-3% -$501K
CVS icon
5
CVS Health
CVS
$137B
$15.8M 3.19%
164,036
-5,192
-3% -$457K
SNDK
6
DELISTED
SANDISK CORP
SNDK
$15.6M 3.14%
158,810
-3,885
-2% -$371K
HUM icon
7
Humana
HUM
$46.7B
$15.1M 3.05%
105,014
-2,303
-2% -$315K
HSP
8
DELISTED
HOSPIRA INC
HSP
$14.4M 2.91%
235,175
-5,526
-2% -$312K
ASH icon
9
Ashland
ASH
$3.04B
$14.1M 2.84%
240,170
-5,856
-2% -$316K
AIG icon
10
American International
AIG
$41.9B
$13.8M 2.8%
247,227
-5,030
-2% -$270K
ETR icon
11
Entergy
ETR
$54.1B
$13.3M 2.69%
304,694
-5,994
-2% -$249K
HPQ icon
12
HP
HPQ
$23.5B
$13M 2.63%
713,056
-10,847
-1% -$182K
OTEX icon
13
Open Text
OTEX
$5.43B
$12.9M 2.61%
444,176
-7,726
-2% -$219K
BIDU icon
14
Baidu
BIDU
$35.8B
$12.8M 2.59%
56,124
-853
-1% -$196K
ADM icon
15
Archer Daniels Midland
ADM
$41.4B
$12.6M 2.54%
241,990
-3,334
-1% -$166K
AMAT icon
16
Applied Materials
AMAT
$426B
$12.5M 2.53%
+502,321
New +$11.3M
FFIV icon
17
F5
FFIV
$22.1B
$12.5M 2.52%
95,474
-1,431
-1% -$178K
VNO icon
18
Vornado Realty Trust
VNO
$7.47B
$12.4M 2.51%
144,341
-1,796
-1% -$144K
CHKP icon
19
Check Point Software Technologies
CHKP
$13.3B
$12.1M 2.44%
153,936
-3,534
-2% -$263K
MJN
20
DELISTED
Mead Johnson Nutrition Company
MJN
$12.1M 2.44%
120,129
-1,653
-1% -$165K
EQR icon
21
Equity Residential
EQR
$25.4B
$12M 2.42%
166,969
-3,224
-2% -$223K
BXP icon
22
Boston Properties
BXP
$11B
$12M 2.42%
92,879
-1,233
-1% -$156K
MMM icon
23
3M
MMM
$89B
$11.9M 2.4%
86,351
-1,510
-2% -$194K
IFF icon
24
International Flavors & Fragrances
IFF
$19.4B
$11.9M 2.4%
116,959
-1,829
-2% -$181K
NSC icon
25
Norfolk Southern
NSC
$78.8B
$11.7M 2.37%
106,843
-1,630
-2% -$179K

Similar funds

Contravisory Investment Management's Q4 2014 Portfolio in Review

As of Q4 2014, Contravisory Investment Management held 182 positions worth $495M, up 3.2% from $480M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Contravisory Investment Management's Q4 2014 filing shows 34 new, 14 increased, 51 reduced and 25 closed positions. Its largest new stake was Johnson & Johnson: 107,956 shares worth $11.3M. The largest sale was Autoliv, an estimated $12.5M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 21% a quarter earlier, followed by Technology and Industrials.

  • Contravisory Investment Management's largest Q4 2014 buy was Johnson & Johnson: 107,956 shares worth $11.3M.
  • Contravisory Investment Management added most to AB InBev in Q4 2014, an estimated $11.1M increase.
  • Contravisory Investment Management's biggest Q4 2014 reduction was Autoliv, cutting an estimated $12.5M.
  • Contravisory Investment Management fully exited Eversource Energy in Q4 2014, selling an estimated $724K.
  • Contravisory Investment Management's ten largest holdings make up 32% of its $495M portfolio in Q4 2014.
  • Contravisory Investment Management opened 34 new positions and closed 25 in Q4 2014.
  • Contravisory Investment Management's portfolio value rose 3.2% quarter-over-quarter to $495M.

Based on Contravisory Investment Management's 13F filing for Q4 2014, filed 12 Jan 2015.